Literature DB >> 24526097

Regional citrate anticoagulation for pediatric CRRT using integrated citrate software and physiological sodium concentration solutions.

Jean-Michel Liet1, Emma Allain-Launay, Bénédicte Gaillard-LeRoux, François Barrière, Alexis Chenouard, Jean-Marc Dejode, Nicolas Joram.   

Abstract

BACKGROUND: In continuous renal replacement therapy (CRRT), regional citrate anticoagulation offers an attractive alternative to heparinization, especially for children with a high bleeding risk.
METHODS: We report on a new management approach to CRRT using integrated citrate software and physiological sodium concentration solutions. Convective filtration was performed with pre-filter citrate anticoagulation using an 18 mmol/L citrate solution and a post-filter replacement fluid. The citrate flow rate was automatically adjusted to the blood flow rate by means of integrated citrate software. Similarly, calcium was automatically infused into children to maintain their blood calcium levels within normal range.
RESULTS: Eleven CRRT sessions were performed (330 h) in seven critically ill children aged 3-15 years (extreme values 15-66 kg). Disease categories included sepsis with multiorgan dysfunction (n = 2) and hemolytic uremic syndrome (n = 5). Median effluent dose was 2.1 (extreme values 1.7-3.3) L/h/1.73 m2. No session had to be stopped because of metabolic complications. Calcium levels, both in the circuits and in the circulating blood of the children, remained stable and secure.
CONCLUSIONS: Regional citrate anticoagulation can be used in children with a body weight of >15 kg using integrated citrate software and commercially available solutions with physiological sodium concentrations in a safe, effective and convenient procedure.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24526097     DOI: 10.1007/s00467-014-2770-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  28 in total

Review 1.  Renal replacement therapies: physiological review.

Authors:  Claudio Ronco; Zaccaria Ricci
Journal:  Intensive Care Med       Date:  2008-09-13       Impact factor: 17.440

Review 2.  Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit.

Authors:  N C Bugg; J A Jones
Journal:  Anaesthesia       Date:  1998-09       Impact factor: 6.955

Review 3.  Continuous renal replacement therapy in children.

Authors:  Scott M Sutherland; Steven R Alexander
Journal:  Pediatr Nephrol       Date:  2012-02-28       Impact factor: 3.714

4.  Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis.

Authors:  N J Maxvold; W E Smoyer; J R Custer; T E Bunchman
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

5.  Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge.

Authors:  Luca Gabutti; Claudio Marone; Giuseppe Colucci; Francesca Duchini; Carlo Schönholzer
Journal:  Intensive Care Med       Date:  2002-09-06       Impact factor: 17.440

6.  Comparison of solute clearance in three modes of continuous renal replacement therapy.

Authors:  Daiva Parakininkas; Larry A Greenbaum
Journal:  Pediatr Crit Care Med       Date:  2004-05       Impact factor: 3.624

7.  Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study.

Authors:  Mehran Monchi; Denis Berghmans; Didier Ledoux; Jean-Luc Canivet; Bernard Dubois; Pierre Damas
Journal:  Intensive Care Med       Date:  2003-11-05       Impact factor: 17.440

8.  Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry.

Authors:  Jordan M Symons; Annabelle N Chua; Michael J G Somers; Michelle A Baum; Timothy E Bunchman; Mark R Benfield; Patrick D Brophy; Douglas Blowey; James D Fortenberry; Deepa Chand; Francisco X Flores; Richard Hackbarth; Steven R Alexander; John Mahan; Kevin D McBryde; Stuart L Goldstein
Journal:  Clin J Am Soc Nephrol       Date:  2007-05-18       Impact factor: 8.237

Review 9.  Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments.

Authors:  Andrew Davenport
Journal:  Pediatr Nephrol       Date:  2012-02-29       Impact factor: 3.714

10.  Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study.

Authors:  Caroline Schultheiß; Bernd Saugel; Veit Phillip; Philipp Thies; Sebastian Noe; Ulrich Mayr; Bernhard Haller; Henrik Einwächter; Roland M Schmid; Wolfgang Huber
Journal:  Crit Care       Date:  2012-08-22       Impact factor: 9.097

View more
  8 in total

1.  Regional citrate anticoagulation for pediatric CRRT using integrated citrate software.

Authors:  Jean-Michel Liet; Gwenaelle Roussey
Journal:  Pediatr Nephrol       Date:  2014-08-07       Impact factor: 3.714

Review 2.  Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.

Authors:  Enrico Fiaccadori; Valentina Pistolesi; Filippo Mariano; Elena Mancini; Giorgio Canepari; Paola Inguaggiato; Marco Pozzato; Santo Morabito
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

3.  Regional citrate anticoagulation for continuous renal replacement therapy in children.

Authors:  Mayerly Prada Rico; Jaime Fernández Sarmiento; Ana María Rojas Velasquez; Luz Stella González Chaparro; Ricardo Gastelbondo Amaya; Hernando Mulett Hoyos; Daniel Tibaduiza; Ana Maria Quintero Gómez
Journal:  Pediatr Nephrol       Date:  2016-11-28       Impact factor: 3.714

4.  Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy.

Authors:  Rupesh Raina; Ronith Chakraborty; Andrew Davenport; Patrick Brophy; Sidharth Sethi; Mignon McCulloch; Timothy Bunchman; Hui Kim Yap
Journal:  Pediatr Nephrol       Date:  2021-10-19       Impact factor: 3.651

Review 5.  Regional citrate anticoagulation for RRTs in critically ill patients with AKI.

Authors:  Santo Morabito; Valentina Pistolesi; Luigi Tritapepe; Enrico Fiaccadori
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-03       Impact factor: 8.237

6.  Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.

Authors:  Keila Rodriguez; Poyyapakkam R Srivaths; Leyat Tal; Mary N Watson; Alyssa A Riley; Ryan W Himes; Moreshwar S Desai; Michael C Braun; Ayse Akcan Arikan
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

7.  Regional citrate anticoagulation with a substitute containing calcium for continuous hemofiltration in children.

Authors:  Ke Bai; Chengjun Liu; Fang Zhou; Feng Xu; Hongxing Dang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

8.  Effect of adult COVID-19 surge on the provision of kidney replacement therapy in children.

Authors:  Akash Deep
Journal:  Pediatr Nephrol       Date:  2020-08-05       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.